Stockreport

Financière de Tubize strengthens its expertise in the biopharma field by appointing 2 new directors [Yahoo! Finance]

Evotec SE  (EVO) 
NASDAQ:AMEX Investor Relations: eatonvance.com
PDF company's board has continued to strengthen its expertise in the biopharma field. This aims to best support UCB and contribute to the development of a sustainable biopha [Read more]